ประเภททั้งหมด
| Product Name | คําอธิบาย | Action |
|---|---|---|
| ซาซิตูซูแม็บ โกวิเทแคน | Trade Name : Trodelvy Target : TROP-2 Molecular Type : ADC Sales in 2025 (Millions of USD) : 1014(First three quarters) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Risankizumab,Skyrizi,Bispecific antibody,BI 655066,Interleukin inhibitor / IL-23 inhibitor,Immunology biologic,Monoclonal Antibody,CAS No.1612838-76-2 การรักษาโรคทางภูมิแพทย์ | Trade Name : Skyrizi Target : Bispecific antibody Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 13000~15000(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch ... |
|
| Tezepelumab, Tesspire, TSLP, แอนติบอดีโมโนคลอนอล, AMG 157, ธาตุชีวภาพที่ต่อต้าน TSLP, ธาตุชีวภาพทางเดินหายใจ / ธาตุชีวภาพที่ต่อต้านอาการหอบหืด, CAS No.1572943-60-0 | Trade Name : Tezspire Target : TSLP Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 826(First half of the year) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Dupilumab,Dupixent,REGN668,อินเตอร์ลิวคินเรเซปเตอร์อินฮิบิตเตอร์,โรคภูมิคุ้มกันทางชีววิทยา,แอนติบอดีโมโนคลอน, CAS No.1190264-60-8 | Trade Name : Dupixent Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 1340(First three quarters) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| ไฮยาลูโรนิเดส, เอนไซม์ / เอนไซม์รีคอมบิแนนท์, สารช่วยในผลิตภัณฑ์ชีวภาพ / ส่วนประกอบร่วมในสูตรผลิตภัณฑ์ชีวภาพ, CAS No.9001-54-1 | Trade Name : N/A Target : N/A Molecular Type : Enzymes Sales in 2025 (Millions of USD) : 1300~1375(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Etanercept, Enbrel, Erelzi, Eticovo, ยาชีวภาพต้าน TNF / TNF inhibitor, โปรตีนฟิวชั่น, CAS No. 185243-69-0 | Trade Name : Enbrel Target : N/A Molecular Type : Fusion Protein Sales in 2025 (Millions of USD) : 2300~2500(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| เพอร์ทูซูแมบ | Trade Name : Perjeta Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 2800(First three quartersestimate ) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch ... |
|
| Tocilizumab | Trade Name : Actemra Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 1280(First half of the year) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
